MedTrace Logo

Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013

NCT01747369 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2017-03-06

No results posted yet for this study

Summary

The aim of this study is to estimate the burden of disease due to pneumococci, other bacteria and viruses in the African meningitis belt prior to pneumococcal conjugate vaccine introduction and to estimate the population impact of the vaccine after its implementation in 2014. In a defined population of a sanitary district in northern Togo, during the period 2010 to 2017, investigators enroll patients of all ages with suspected pneumonia requiring hospitalization or suspected bacterial meningitis. Patients are evaluated by bacteriology and molecular biology techniques on blood, cerebro-spinal fluid, nasal aspirates and by chest X-ray.

Conditions

  • Pneumonia, Bacterial
  • Pneumonia, Viral
  • Meningitis, Bacterial

Sponsors & Collaborators

  • Region Sanitaire des Savanes, Togo

    collaborator UNKNOWN

  • Ministere de la Sante et de la Promotion Sociale, Togo

    collaborator UNKNOWN

  • Institut National d'Hygiene, Togo

    collaborator UNKNOWN

  • Centre Muraz

    collaborator OTHER

  • Fondation Mérieux, France

    collaborator UNKNOWN

  • Pfizer

    collaborator INDUSTRY

  • Agence de Médecine Préventive, France

    lead OTHER

Principal Investigators

  • Jennifer C Moïsi, PhD · Agence de Médecine Préventive

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Togo

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01747369 on ClinicalTrials.gov